Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.37 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL844528 | 1.00 | PRKCI (0.37) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL13859420 | 1.00 | PRKCI (0.37) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL29669260 | 0.99 | PRKCI (0.36) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL29631485 | 0.99 | PRKCI (0.36) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL14575073 | 0.97 | PRKCI (0.35) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL14846491 | 0.97 | PRKCI (0.35) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL26448827 | 0.95 | PRKCI (0.34) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL526002 | 0.91 | HSD17B1 (0.41) | HSD17B1HSD17B2RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL12578149 | 0.89 | HSD17B1 (0.44) | PRKCIHSD17B1HSD17B2RAB9AMAPT | |
| SCHEMBL526704 | 0.89 | HSD17B1 (0.39) | HSD17B1HSD17B2RAB9AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116917271-B | Process for producing arylthiol ester compound | ＡＧＣ株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-20230406819-A1 | METHOD FOR PRODUCING ARYL THIOL ESTER COMPOUND | AGC Inc. (JP) | 2023-12-21 | — | — | US | disclosed |
| WO-2022186305-A1 | PRODUCTION METHOD OF ARYLTHIOL ESTER COMPOUND | ＡＧＣ株式会社 | 2022-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406819-A1 | METHOD FOR PRODUCING ARYL THIOL ESTER COMPOUND | TST, SULT1A1, STS | PRKCI 4632/4885HSD17B1 560/4885HSD17B2 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.